129: Why Is Testosterone Still Off-Limits for Women?

Testosterone in women is finally getting more attention, but what does that actually mean for women and their care? In this episode, I sit down with Dr. Terri DeNeui to discuss the FDA’s focus on testosterone, why there still isn’t an FDA-approved testosterone treatment specifically for women, and the questions surrounding safety, dosing, and access.

We also talk about symptoms of testosterone deficiency, why “normal” lab ranges don’t always tell the full story, and the larger conversation around medical freedom and individualized care.

Topics We Cover in This Episode: 

Why testosterone matters for women

What the FDA is currently considering

Why testosterone remains a controlled substance

When symptoms can appear

Why “normal” labs may not tell the whole story

How dosing and delivery methods matter

Where medical freedom fits into the conversation

Tune in to hear Dr. Terri DeNeui’s perspective on where women’s testosterone care stands today, what still needs to change, and what patients should be asking.

Resources & Links